Cargando…

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis

The use of cannabis flowering tops with standardized amounts of active phytocannabinoids was recently authorized in several countries to treat several painful pathological conditions. The acute pharmacological effects and disposition of Δ-9-tetrahydrocannabinol (THC), cannabidiol (CBD), their acidic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Acevedo, Ana Pilar, Busardò, Francesco Paolo, Pacifici, Roberta, Mannocchi, Giulio, Gottardi, Massimo, Poyatos, Lourdes, Papaseit, Esther, Pérez-Mañá, Clara, Martin, Soraya, Di Trana, Annagiulia, Pichini, Simona, Farré, Magí
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763054/ https://www.ncbi.nlm.nih.gov/pubmed/33322849 http://dx.doi.org/10.3390/ph13120459

Ejemplares similares

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
por: Busardò, Francesco Paolo, et al.
Publicado: (2021)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2020)

Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans
por: Di Giorgi, Alessandro, et al.
Publicado: (2023)

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users
por: Maida, Nunzia La, et al.
Publicado: (2021)

Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users
por: Di Trana, Annagiulia, et al.
Publicado: (2022)

Determination of the Synthetic Cannabinoids JWH-122, JWH-210, UR-144 in Oral Fluid of Consumers by GC-MS and Quantification of Parent Compounds and Metabolites by UHPLC-MS/MS
por: La Maida, Nunzia, et al.
Publicado: (2020)

Acute Pharmacological Effects and Oral Fluid Concentrations of the Synthetic Cannabinoids JWH-122 and JWH-210 in Humans After Self-Administration: An Observational Study
por: Martínez, Lucia, et al.
Publicado: (2021)

Usefulness of Oral Fluid for Measurement of Methylone and Its Metabolites: Correlation with Plasma Drug Concentrations and the Effect of Oral Fluid pH
por: Sprega, Giorgia, et al.
Publicado: (2023)

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans
por: Poyatos, Lourdes, et al.
Publicado: (2022)

Interaction of Energy Drinks with Prescription Medication and Drugs of Abuse
por: Hladun, Olga, et al.
Publicado: (2021)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Pharmacological effects of methylone and MDMA in humans
por: Poyatos, Lourdes, et al.
Publicado: (2023)

GC–MS/MS Determination of Synthetic Cathinones: 4-chloromethcathinone, N-ethyl Pentedrone, and N-ethyl Hexedrone in Oral Fluid and Sweat of Consumers under Controlled Administration: Pilot Study
por: Nuñez-Montero, Melani, et al.
Publicado: (2023)

Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors
por: Brunetti, Pietro, et al.
Publicado: (2020)

New Psychoactive Substances Consumption in Opioid-Use Disorder Patients
por: Alías-Ferri, Maria, et al.
Publicado: (2022)

Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
por: Malaca, Sara, et al.
Publicado: (2021)

Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair
por: Busardò, Francesco Paolo, et al.
Publicado: (2019)

Drug Interactions With New Synthetic Opioids
por: Pérez-Mañá, Clara, et al.
Publicado: (2018)

A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure
por: Poyatos, Lourdes, et al.
Publicado: (2021)

Abuse Potential of Cathinones in Humans: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2022)

Cannabinoids: from pot to lab
por: Papaseit, Esther, et al.
Publicado: (2018)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

Editorial: New Trends of Substance Abuse: Looking for New Psychotropic Effects of Chem Sex Drugs, Cognitive Enhancers, and New Psychoactive Substances
por: Pichini, Simona, et al.
Publicado: (2020)

EDITORIAL: New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects
por: Pichini, Simona, et al.
Publicado: (2017)

Ultra-High Performance Liquid Chromatography-High Resolution Mass Spectrometry and High-Sensitivity Gas Chromatography-Mass Spectrometry Screening of Classic Drugs and New Psychoactive Substances and Metabolites in Urine of Consumers
por: Marchei, Emilia, et al.
Publicado: (2021)

European Drug Users at Risk from Illicit Fentanyls Mix
por: Pichini, Simona, et al.
Publicado: (2017)

Editorial: Psychiatric and Pharmacotoxicological Insights on Appearance and Performance Enhancing Drugs
por: Zaami, Simona, et al.
Publicado: (2022)

Bilastine vs. hydroxyzine: occupation of brain histamine H(1)-receptors evaluated by positron emission tomography in healthy volunteers
por: Farré, Magí, et al.
Publicado: (2014)

Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids
por: Solimini, Renata, et al.
Publicado: (2018)

Editorial: The Challenge Posed by New Synthetic Opioids: Pharmacology and Toxicology
por: Pichini, Simona, et al.
Publicado: (2019)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence
por: Mas, Marta, et al.
Publicado: (2022)

UHPLC-HRMS and GC-MS Screening of a Selection of Synthetic Cannabinoids and Metabolites in Urine of Consumers
por: Pellegrini, Manuela, et al.
Publicado: (2020)

Non-allowed Pharmacologically Active Substances in Physical and Sexual Performance Enhancing Products
por: Pellegrini, Manuela, et al.
Publicado: (2017)

Acute Pharmacological Effects of 2C-B in Humans: An Observational Study
por: Papaseit, Esther, et al.
Publicado: (2018)

The challenging issue of polydrug consumption: new trends of a deep-seated public health threat
por: Di Trana, Annagiulia
Publicado: (2022)

Soy Isoflavone Extract Does Not Increase the Intoxicating Effects of Acute Alcohol Ingestion in Human Volunteers
por: Martínez-Riera, Roser, et al.
Publicado: (2019)

Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances
por: Di Trana, Annagiulia, et al.
Publicado: (2022)

Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry Assay for Determination of Endogenous GHB and GHB-Glucuronide in Nails
por: Busardò, Francesco Paolo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7jjh641hjmt14s2pfq92mv5s3i